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Activating and inhibitory cell surface receptors play im-
portant roles in regulation of immune responses. Recent 
progress has demonstrated that many inhibitory receptors 
pair with activating, as well as inhibitory, isoforms, both of 
whose genes are located in small clusters on a chromosome. 
We and others identified paired activating and inhibitory im-
munoglobulin-like receptors, designated myeloid-associated 
immunoglobulin-like receptors (MAIR) (CD300). MAIR is a 
multigene family consisting of nine genes on a small segment 
of mouse chromosome 11. MAIR family receptors are prefer-
entially expressed on myeloid cells, including macrophages, 
dendritic cells, granulocytes, and bone-marrow-derived cul-
tured mast cells, and a subset of B cells and regulate activa-
tion of these cells. Thus, MAIR plays an important role in in-
nate immunity mediated by myeloid cells. 
[Immune Network 2009;9(2):41-45]
INTRODUCTION
Activating and inhibitory cell surface receptors play important 
roles in regulation of immune responses (1,2). The immune 
inhibitory  receptors  contain  immunoreceptor  tyrosine-based 
inhibitory motif (ITIM) in their cytoplasmic domains. The pro-
totype 6-amino acid sequence for ITIM is (I/V/L/S)-x-Y-x-x- 
(L/V) (x denotes any amino acid), whose tyrosine is phos-
phorylated upon ligand binding, providing a docking site for 
the recruitment of Src homology 2 (SH2)-containing cytoplas-
mic phosphatases (3,4) and shutting down activation signals 
by dephosphorylation of intracellular substrates at the earliest 
steps  of  the  activation  response.
    In contrast, the activating receptors have a short cytoplas-
mic domain and contain a charged amino acid residue in the 
transmembrane region, which is involved in association with 
immunoreceptor tyrosine-based activating motif (ITAM)-bear-
ing adaptor transmembrane proteins, such as Fc RI or DAP12, 
or with DAP10 adaptor containing PI3 kinase binding motif 
(5,6). These adapter proteins are tyrosine phosphorylated by 
the src family protein tyrosine kinases (PTKs) Syk or Zap70 
upon ligand binding, resulting in activation of down stream 
signaling  molecules  in  lymphoid  and  myeloid  cells.  Recent 
progress has demonstrated that many inhibitory receptors pair 
with activating, as well as inhibitory, isoforms (2,7), both of 
whose genes are located in small clusters on a chromosome 
(8).
    Myeloid cells, including neutrophils and macrophages, play 
an essential role for host defenses against infectious microbial 
pathogens (9). Myeloid cells are activated through a vast ar-
ray  of  cell  surface  receptors,  such  as  Fc  receptors  for  IgG, 
β 2  integrins,  complement  receptors,  chemokines,  cytokine 
receptors and Toll-like receptors, and mediate phagocytosis, 
degranulation of anti-microbial substances or secretion of in-
flammatory mediators. However, how activation of myeloid 
cells is regulated is incompletely understood. We and others 
identified  and  characterized  paired  activating  and  inhibitory 
immunoglobulin-like  receptors,  designated  myeloid-associa-
ted immunoglobulin-like receptors (MAIR)-I and MAIR-II and 
MAIR-IV and MAIR-V, whose extracellular domains are highly 
conserved with each other, respectively. In this review, we 
describe molecular and functional characteristics of the MAIR. Regulation of Immune Responses by MAIR (CD300)
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Figure 1. Molecular characteristics of 
MAIR. MAIR family receptors belong to 
immunoglobulin superfamily with one 
immunoglobulin domain in the extracel-
lular portion. MAIR-I and MAIR-II and 
MAIR-V and MAIR-IV are paired inhibi-
tory and activating receptors, respective-
ly, with high homology in the extracel-
lular portion each other. MAIR-I and 
MAIR-V contain immunoreceptor tyrosi-
ne-based inhibitory motif (ITIM) in their 
cytoplasmic domains and mediate inhi-
bitory signals. MAIR-II and MAIR-IV as-
sociates immunoreceptor tyrosine-based 
activating motif (ITAM)-bearing adaptor 
transmembrane proteins Fc RI or DAP12
and mediate activation signals.
Figure 2. Gene localization of MAIR family. Mouse and human MAIR family genes are mapped on chromosome 11 and 17, respectively.
IDENTIFICATION OF THE MAIR 
To  identify  novel  genes  encoding  cell  surface  receptors  in-
volved in immune responses by myeloid cells, we performed 
representative  differential  analysis  (RDA)  which  is  a  PCR- 
based subtractive hybridization, using day 14 fetal livers from 
PU.1-/-mice  lacking  myeloid  cells  and  control  littermates. 
Among several cDNA clones unique to myeloid cells identi-
fied, we found a novel gene encoding a member of the Ig 
superfamily, designated MAIR-I. The cytoplasmic domain of 
MIAR-I  contains  the  ITIM-like  sequences  (VEY
258STL  and 
LHY
270SSV,  respectively)  based  on t h e  c o n s e n s u s  s e q u e n c e  
for ITIMs (I/V/L/SxYxxL/V) (Fig. 1), suggesting that MAIR-I 
may  recruit  protein  tyrosine  phosphatases  and  mediates  in-
hibitory signals. We also identified a clone encoding the pro-
tein, designated MAIR-II, which contains one Ig-like domain 
with 92% amino acid identity to that of MAIR-I in extracellular 
domain, a transmembrane region with a charged aa (Lys) and 
a  short  (20  aa)  cytoplasmic  tail  (Fig.  1).  The  MAIR-I  and 
MAIR-II genes are located to the proximal region of E2 band 
of  mouse  chromosome  11.  MAIR-I  and  MAIR-II  are  also 
named as CLM8/LMIR1 and CLM4/LMIR2/DIgR1, respectively 
(10-12).
  By screening a database for the mouse genome, we and 
others found that MAIR-I and MAIR-II are members of a multi-
gene family consisting of nine genes on a small segment of 
mouse  chromosome  11  (11,13)  (Fig.  2). 
    We  cloned  all  the  full-length  cDNAs  of  the  MAIR  family 
genes other than MAIR-I and MAIR-II by PCR from the spleen 
of C57BL/6 mice and designated them as MAIR-III to MAIR- 
IX, based on a phylogenetic tree analysis (Fig. 3). We found 
that one of the genes, MAIR-IV, has a short cytoplasmic tail 
(24 aa) with no signaling motif and a negatively charged glu-
tamic acid (E) in its transmembrane (TM) region (Fig. 1). The 
Ig-like  domain  of  MAIR-IV  in  the  extracellular  portion  has 
91% identity with that of MAIR-V at the amino acid level. In Regulation of Immune Responses by MAIR (CD300)
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Figure 3. Molecular phylogenetic tree of MAIR gene family. Phylogenetic analysis of the MAIR family genes was performed by using the UPGMA 
method of GENETYX-MAC software (Software develoment, Tokyo, Japan). MAIR-II, MAIR-III, MAIR-VII and MAIR-VIII contained a charged amino 
acid in the transmembrane portion, and some of them associate with ITAM-bearing adaptor. MAIR-I and MAIR-V contains ITIM in the cytoplasmic 
portion.
contrast to MAIR-IV, MAIR-V has a long cytoplasmic tail con-
taining  two  consensus  immunoreceptor  tyrosine-based  in-
h i b i t o r y  m o t i f  ( I T I M ) ,  s u g g e s t i n g  t h a t  M A I R - I V  a n d  M A I R - V  
constitute paired activating and inhibitory receptors (Fig. 1).  　
MAIR-IV and MAIR-V were also named as CLM5 and CLM1/ 
DIgR2 (11,14,15), respectively. The MAIR family was found 
to be a murine counterpart of the human CMRF-35 (CD300) 
family (16-18), which is located on human chromosome 17, 
syntenic  region  of  mouse  chromosome  11  (Fig.  2).
EXPRESSION AND FUNCTION OF MAIR-I AND 
MAIR-II, PAIRED INHIBITORY AND ACTIVATING 
RECEPTORS, RESPECTIVELY
MAIR-I is expressed on the majority of myeloid cells, includ-
ing macrophages, dendritic cells, granulocytes, and bone-mar-
row-derived cultured mast cells, and a subset of B cells, but 
neither on T nor NK cells (19). In contrast, MAIR-II protein 
is detected only on cell surface of subsets of B cells and peri-
toneal  macrophages  (19,20).
    MAIR-I contains the ITIM sequences in the cytoplasmic do-
main and inhibits IgE-mediated degranulation from mast cells 
(19). Analyses by using the transfectant of rat basophil leuke-
mia RBL-2H3 expressing wild type or variable mutant MAIR-I 
at Y
233, Y
258, Y
270 and/or Y
299 demonstrated that both Y
258 and 
Y
270, but not Y
233 and Y
299, were phosphorylated and recruits 
SHP-1and SHIP upon cross-linking of MAIR-I, which were es-
sentially required for inhibition of IgE-mediated degranulation 
from  the  RBL-2H3  transfectant  (21). 
  MAIR-II associates with the immunoreceptor tyrosine-based 
activation motif-bearing adaptor DAP12 and stimulates pro-in-
f l a m m a t o r y  c y t o k i n e s  a n d  c h e m o k i n e  s e c r e t i o n s  f r o m  p e r i -
toneal macrophages (19). However, we found that cross-link-
ing MAIR-II with monoclonal antibody induced secretion of 
significant amount of the inflammatory cytokines TNF-α  and 
IL-6  from  DAP12-/-  as  well  as  wild  type  peritoneal  macro-
phages. Further studies demonstrated that MAIR-II associates 
with not only DAP12 but also FcR γ   chain homodimers in per-
i t o n e a l  m a c r o p h a g e s  ( 2 0 ) .  T h e s e  f i n d i n g s  p r e s e n t  t h e  f i r s t  
case of an activating receptor that uses either DAP12 or FcRγ Regulation of Immune Responses by MAIR (CD300)
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chain  as  a  signaling  adapter.
EXPRESSION AND FUNCTION OF MAIR-IV AND 
MAIR-V, PAIRED ACTIVATING AND INHIBITORY 
RECEPTORS, RESPECTIVELY
MAIR-IV  was  preferentially  expressed  on  Gr-1
high/Mac-1
＋ 
neutrophils  from  the  peripheral  blood,  bone  marrow,  peri-
toneal  cavity  and  spleen.  MAIR-IV  was  also  expressed  on 
Mac-1
＋/Gr-1
－ macrophages from the spleen and bone mar-
row and CD11c
＋ dendritic cells (DC), but not on T, B, NK 
cells  or  bone  marrow-derived  cultured  mast  cells  (13). 
MAIR-IV contains a short cytoplasmic tail with no signaling 
motif, suggesting that MAIR-IV, like MAIR-II, mediates activat-
ing signals via ITAM-containing adapter proteins, such as FcR-
γ  chain or DAP12. DAP12 associates with several activating 
NK  receptors  and  myeloid  cell-specific  receptors,  including 
human and mouse TREM-1, TREM-2, MDL-1, and PILRβ , SIRP
β 1,  mouse  TREM-3  and  CD200R3,  CD200R4  and  mouse 
MAIR-II, all of which contain a positively charged amino acid, 
such as lysine (K) or arginine (R), in their TM region (22). 
In  contrast,  FcRγ  c h a i n  i s  a l s o  a b l e  t o  a s s o c i a t e  w i t h  r e -
ceptors, such as Fcγ RIIIA and Fcε RI, which do not contain 
a  positively  charged  amino  acid  in  the  TM  region  (23). 
Because MAIR-IV does not possess a positively charged ami-
no  acid  in  the  TM  region,  FcRγ  c h a i n  m i g h t  b e  a  p a r t n e r  
o f  M A I R - I V .  I n  f a c t ,  M A I R - I V  a s s o c i a t e  w i t h  F c R γ  c h a i n  i n 
peritoneal  macrophages  as  well  as  transfectants  expressing 
MAIR-IV  (13,14).  Because  MAIR-IV  associates  with  FcRγ 
chain,  it  may  mediates  an  activating  signal  in  neutrophils. 
Stimulation of MAIR-IV with plate-coated F(ab')2 fragments of 
a n t i - M A I R - I V  m A b  i n d u c e d  T N F - α   and  IL-6  secretion  from 
neutrophils  or  peritoneal  exudatative  cells,  indicating  that 
MAIR-IV  is  a  novel  activating  receptor  on  neutrophils.
    MAIR-V  (CD300LF)  was  expressed  on  macrophages,  but 
not on B cells, T cells or granulocytes, derived from the sple-
en and peritoneal cavity (24). Cross-linking MAIR-V with anti- 
MAIR-V monoclonal antibody induced cell death in peritoneal 
macrophages  as  well  as  in  several  transfectants  expressing 
MAIR-V. 
    Scanning electron microscopy revealed loss of blebs from 
the surface of the dead cells mediated by MAIR-V, a morpho-
logical  feature  similar  to  that  observed  in  apoptotic  cells. 
However, further studies revealed that MAIR-V mediates cas-
pase  and  ER  stress-independent  cell  death  by  a  novel 
mechanism.
CONCLUDING REMARKS
MAIR family receptors are preferentially expressed on mye-
loid  cells,  including  macrophages,  dendritic  cells,  gran-
ulocytes, mast cells, and a subset of B cells and regulate acti-
vation of these cells. It is not clear at present how these acti-
vating and inhibitory receptors cooperate each other for regu-
lation of immune responses by myeloid cells. To understand 
t h e  r o l e  o f  M A I R  f a m i l y  r e c e p t o r s  i n  i m m u n e  r e s p o n s e s ,  i t  
is essentially required to identify their ligands and character-
ize  the  receptor-ligand  interaction  in  vivo.
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